Utama › Kolitis Ulseratif
Kajian klinikal Kolitis Ulseratif sedang mengambil peserta di AS
79 kajian untuk Kolitis Ulseratif sedang mengambil peserta di lokasi seluruh Amerika Syarikat.
Bandar dengan paling banyak kajian
- New York City, NY23 kajian
- Orlando, FL22 kajian
- Miami, FL21 kajian
- Houston, TX17 kajian
- San Antonio, TX16 kajian
- Chicago, IL15 kajian
- Tacoma, WA15 kajian
- San Diego, CA15 kajian
- Tyler, TX14 kajian
- Colorado Springs, CO14 kajian
- Los Angeles, CA13 kajian
- St. Louis, MO13 kajian
- Washington, DC12 kajian
- Boston, MA11 kajian
- Cincinnati, OH11 kajian
- Providence, RI11 kajian
- Louisville, KY10 kajian
- Lewisville, TX10 kajian
- Durham, NC10 kajian
- Parma, OH10 kajian
- Tampa, FL9 kajian
- Lubbock, TX9 kajian
- Evanston, IL9 kajian
- Atlanta, GA9 kajian
- Baltimore, MD8 kajian
- Mountain View, CA8 kajian
- Garland, TX8 kajian
- Memphis, TN8 kajian
- Round Rock, TX8 kajian
- Scottsdale, AZ8 kajian
- Metairie, LA8 kajian
- Dallas, TX8 kajian
- Cleveland, OH8 kajian
- Seattle, WA8 kajian
- Pittsburgh, PA7 kajian
- Waukegan, IL7 kajian
- Fort Worth, TX7 kajian
- Charlotte, NC7 kajian
- Anaheim, CA7 kajian
- Wyoming, MI7 kajian
Mengikut negeri
- Alabama7 kajian
- Arizona19 kajian
- Arkansas4 kajian
- California39 kajian
- Colorado17 kajian
- Connecticut11 kajian
- Florida31 kajian
- Georgia14 kajian
- Idaho4 kajian
- Illinois24 kajian
- Indiana10 kajian
- Kansas10 kajian
- Kentucky13 kajian
- Louisiana15 kajian
- Maryland13 kajian
- Massachusetts16 kajian
- Michigan17 kajian
- Minnesota8 kajian
- Mississippi6 kajian
- Missouri16 kajian
- Nevada6 kajian
- New Hampshire5 kajian
- New Jersey7 kajian
- New York30 kajian
- North Carolina23 kajian
- Ohio26 kajian
- Oklahoma4 kajian
- Oregon5 kajian
- Pennsylvania12 kajian
- Rhode Island11 kajian
- South Carolina12 kajian
- South Dakota4 kajian
- Tennessee12 kajian
- Texas33 kajian
- Utah7 kajian
- Virginia14 kajian
- Washington22 kajian
- Wilayah Columbia3 kajian
- Wisconsin4 kajian
Kajian yang dikemas kini baru-baru ini
Teks kajian rasmi (Bahasa Inggeris)
Longitudinal Immunophenotyping of Patients With Inflammatory Bowel Disease
Mengambil pesertaKajian pemerhatian
Umur 18 hingga 85 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT07619547Aquamin® for Prevention of Ulcerative Colitis J-Pouch-associate Intestinal Inflammation
Mengambil pesertaFasa 2
Umur 18 hingga 80 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT07501078Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
Mengambil pesertaFasa 3
Semua umur · Semua jantina · Dikemas kini 2 Okt 2026 · NCT06651281Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
Mengambil pesertaFasa 2
Umur 18 hingga 75 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT07697456A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
Mengambil pesertaFasa 4
Umur 18 hingga 80 · Semua jantina · Dikemas kini 30 Sep 2026 · NCT06581328A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis
Mengambil pesertaFasa 3
Umur 2 hingga 17 · Semua jantina · Dikemas kini 30 Sep 2026 · NCT07071519Confirmatory Clinical Study in Active Ulcerative Colitis
Mengambil pesertaFasa 2
Umur 16 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT07296315A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
Mengambil pesertaFasa 2
Umur 18 hingga 75 · Semua jantina · Dikemas kini 30 Sep 2026 · NCT06598943Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
Mengambil pesertaFasa 1/2Sukarelawan sihat dialu-alukan
Umur 18 hingga 75 · Semua jantina · Dikemas kini 29 Sep 2026 · NCT06619990A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
Mengambil pesertaFasa 2
Umur 18 hingga 75 · Semua jantina · Dikemas kini 29 Sep 2026 · NCT07012395A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
Mengambil pesertaFasa 2
Umur 18 hingga 75 · Semua jantina · Dikemas kini 29 Sep 2026 · NCT07845487A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002)
Mengambil pesertaFasa 2
Umur 18 hingga 75 · Semua jantina · Dikemas kini 28 Sep 2026 · NCT07463183A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Sep 2026 · NCT06979336Immune Regulation in Ulcerative Colitis or Crohn s Disease
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
1 Day – 75 Years · Semua jantina · Dikemas kini 28 Sep 2026 · NCT00001184A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
Mengambil pesertaFasa 3
Umur 12 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07196748A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
Mengambil pesertaFasa 3
Umur 3 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT06663332A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
Mengambil pesertaFasa 2/3
Umur 2 hingga 17 · Semua jantina · Dikemas kini 24 Sep 2026 · NCT05076175Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Mengambil pesertaFasa 3
Umur 18 hingga 70 · Semua jantina · Dikemas kini 24 Sep 2026 · NCT06937086Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 23 Sep 2026 · NCT03816345LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
Mengambil pesertaFasa 2
Umur 18 hingga 80 · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07186101A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
Mengambil pesertaFasa 2
Umur 18 hingga 80 · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07483073A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
Mengambil pesertaFasa 3
Umur 2 hingga 19 · Semua jantina · Dikemas kini 22 Sep 2026 · NCT04844606LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Mengambil pesertaFasa 2
Umur 18 hingga 80 · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07415044A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
Mengambil pesertaFasa 4
Umur 18 hingga 65 · Semua jantina · Dikemas kini 21 Sep 2026 · NCT06095128Proof of Concept Study Evaluating the Efficacy and Safety of ATH-063 Treatment in Patients With Relapsed/Refractory Moderately to Severely Active Ulcerative Colitis (UC)
Mengambil pesertaFasa 2
Umur 18 hingga 75 · Semua jantina · Dikemas kini 21 Sep 2026 · NCT07513181Daripada ClinicalTrials.gov, data diperoleh pada 4 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.